100 likes | 125 Views
ABSSSI market report by DelveInsight gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology.<br>For more information on ABSSSI market, click here: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
E N D
Acute Bacterial Skin and Skin Structure Infections
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 01 ABSSSI is defined as a bacterial infection of Skin with a lesion size area of ≥75 cm2. 02 ABSSSI consists of the most frequently diagnosed skin infections worldwide. 03 ABSSSI types can be community-acquired or hospital-acquired, and the predisposing factors include trauma, chronic cutaneous lesionsetc. 04 The ABSSSI symptoms observed are extensive cellulitis, wound infection, major cutaneous abscesses, and burn infections. 05 Despite recent ABSSSI antibiotic launches, unmet needs still exist for an oral anti-MRSA agent. • DelveInsight © 2019 | All rights reserved
ABSSSI Epidemiology • In United States, more than 15 million bacterial skin and skin structure infections occur. • ABSSSItotal 7MM*Incident cases in 2017 were 7,259,777, out of which ABSSSIhighest Incident cases were seen in the United States. • There were 1,942,229 male patients and 1,406,442 female cases suffering from ABSSSI in 2017 in the United States. *7MM:- Unites States; EU 5 (Germany, France, Spain, Italy, United Kingdom); Japan. • DelveInsight © 2019 | All rights reserved
ABSSSI Treatment ABSSSI treatment includes an antimicrobial therapy, surgical drainage, and antibiotic therapy. Oral and intravenous options for ABSSSI treatment with activity against MRSA include several long-standing therapies, such as clindamycin, doxycycline etc. A large number of upcoming pipeline drugs, is expected to create a lucrative environment for growth of ABSSSI treatment market. The ABSSSI therapeutic approaches favored in treating skin infections include adjunctive therapies, early and appropriate empiric antibiotic therapy, wound culture with susceptibility testing and surgical drainage and debridement. • DelveInsight © 2019 | All rights reserved
Marketed Drugs 01 Drug- Orbactiv Company- The Medicines Company 02 Drug- Sivextro Company- Cubist Pharmaceutical 03 Drug- Nuzyra Company- Paratek Pharmaceutical 04 Drug- Baxdela Company- Melinta • DelveInsight © 2019 | All rights reserved
Complete Information For complete information on Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) -Market Insights, Epidemiology &Market Forecast-2028 please click the link below CLICK HERE OR Write Us At info@delveinsight.com • DelveInsight © 2019 | All rights reserved
About DelveInsight 2 1 3 Mission About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved
Service Offerings by DelveInsight 2 8 3 1 6 4 5 7 Market Intelligence Opportunity Assessment Forecasting PharmDelve Competitive Analysis Pipeline Consulting Report Store • DelveInsight © 2019 | All rights reserved
Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2018 | All rights reserved